Next Article in Journal
Morphology and Metal Binding Characteristics of a Natural Polymer—Kondagogu (Cochlospermum gossypium) Gum
Next Article in Special Issue
Cytotoxic Aporphine Alkaloids from Leaves and Twigs of Pseuduvaria trimera (Craib)
Previous Article in Journal
Studies toward the First Stereoselective Total Synthesis of (±)-Quinolizidine 195C and Other Transformations
Previous Article in Special Issue
Chromone and Flavonoid Alkaloids: Occurrence and Bioactivity
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

The Pharmacological Activities of (−)-Anonaine

School of Medical and Health Sciences, Fooyin University, Kaohsiung 83102, Taiwan
*
Authors to whom correspondence should be addressed.
Molecules 2013, 18(7), 8257-8263; https://doi.org/10.3390/molecules18078257
Submission received: 13 May 2013 / Revised: 28 June 2013 / Accepted: 3 July 2013 / Published: 12 July 2013
(This article belongs to the Special Issue Alkaloids: Novel Therapeutic Perspectives)

Abstract

:
Several species of Magnoliaceae and Annonaceae are used in Traditional Chinese Medicine. (−)-Anonaine, isolated from several species of Magnoliaceae and Annonaceae, presents antiplasmodial, antibacterial, antifungal, antioxidation, anticancer, antidepression, and vasorelaxant activity. This article provides an overview of the pharmacological functions of (−)-anonaine.

1. Introduction

Various constituents of Michelia alba (Magnoliaceae) are used for medical purposes. In our research, we have identified a series of compounds from Michelia alba, including (−)-anonaine (Figure 1A) [1], an aporphine (isoquinoline) alkaloid also isolated from other plants (Table 1) with interesting and varied biological and pharmacological activities, including vasorelaxant, antibacterial, antifungal, antioxidative, anticancer and antidepressant effects, as summarized in Table 1 [1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32]. In this article, we will focus on describing the pharmacological mechanisms of action of (−)-anonaine.

2. Anticancer Activity

There are three different mechanisms by which a cell commits suicide by apoptosis. One is initiated by signals arising within the cells. The second is triggered by death activators binding to receptors at the cell surface. The third is triggered by reactive oxygen species (ROS).
Studies have demonstrated that (−)-anonaine has anticancer activity and cytotoxic effects in different cancer cell lines [6,7,15]. The viability of cells treated with (−)-anonaine decreased in a dose-dependent manner on different cell lines including HeLa, HepG2, rat hepatocytes, and H1299 [6,7,15]. In human cervical cancer cell (HeLa), (−)-anonaine caused DNA damage associated with increased intracellular nitric oxide, ROS, glutathione (GSH) depletion, disruptive mitochondrial transmembrane potential, activation caspase 3, 7, 8 & 9 activation and poly ADP ribose polymerase cleavage [15]. Moreover, (−)-anonaine also up-regulates the protein expression of p53 and Bax [15]. (−)-Anonaine is a potential anticancer agent against HepG2 (human liver carcinoma cell), rat hepatocyte with IC50 values of 33.5, 70.3 μg/mL [7]. This compound also exhibits antiproliferation, antimigratory effects, DNA damage and cell cycle arrest in human lung cancer cell (H1299) [6]. The above-mentioned results indicate that (−)-anonaine has cytotoxic activity (Scheme 1).

3. Vasorelaxation Activity

Reports have shown that aporphine alkaloids display a variety of different pharmacological activites in cardiovascular system [16,20,26]. (−)-Anonaine has Ca2+ channel blocking activity through voltage-operated channel and α1-adrenoceptor blocking activity in isolated rat thoracic aorta [20]. Recently, a study has shown that the affinities of (−)-anonaine for α1-adrenoceptor subtypes are in the order α1A>α1D>α1B without inhibition phosphodiesterase enzymatic activity [16]. Further, this study confirms that α1-adrenoceptor subtypes selectivity of aporphine alkaloids can be modulated by the position of free hydroxyl (R2) and N-methyl (R1) substituents on the aporphine structure (Figure 1B) [16].

4. Antioxidative Activity

Oxidative stress is an imbalance of prooxidants and antioxidants in the organism. The oxidative stress can contribute to inflammation, heart disease, hypertension, various neurodegenerative diseases, and cancers. Anti-oxidative capacity of anonaine has been studied as a potential inhibitor of lipid peroxidation stimulated by Fe2+/cysteine in rat liver microsomal fractions [25]. The antioxidation activity of anonaine was also evaulated monitoring inhibition of microsomal lipid peroxidation induced by Fe2+/ascorbate, CCl4/NADPH or Fe3+ ADP/NADPH [21]. However, one study demonstrated that anonaine increased deoxyribose degradation by generated hydroxyl radical. This effect was determined by thiobarbituric acid method in the incubation medium Fe3+-EDTA and H2O2 [22].

5. Central Nervous System (CNS) Activity

Depression is a common mental disorder all over the World. Several species of Annonaceae are used in traditional medicine because of their anti-anxiety, anticonvulsant, and tranquilizing properties [2]. Previous study has shown that (−)-anonaine has good selectivity for 3H-dopamine uptake. The affinity of (−)-anonaine at dopamine D1 3H-SCH 23390 and D2 3H-raclopride binding sites was low [19]. (−)-Anonaine displays dopamine uptake inhibitory properties. 5-HT1A receptor plays an important role in depressive disorders. One study has shown that 1,2-dimethoxy-5,6,6a,7-tetrahydro-4H-dibenzoquinoline-3,8,9,10-tetraol, (−)-anonaine, liriodenine, and nornuciferine are the main constituents of the aerial parts of Annona cherimola [2]. These main constituents produced antidepression-like effects due to the 5-HT1A receptor agonistic activity of (−)-anonaine and nornuciferine [2]. These results indicate that (−)-anonaine displays dopamine uptake inhibitory and 5-HT1A agonistic activity with anti-depressant activity.
Another study reported that (−)-anonaine at 0.05 μM reduced tyrosine hydroxylase (TH) and aromatic L-amino acid decarboxylase (AADC) activity [13]. In addition, (−)-anonaine at 0.05 μM reduced L-DOPA (50 μM and 100 μM)-induced increase in dopamine content without enhancing L-DOPA-induced cell death in PC12 cells at 24 h [13].

6. Antiparasitic Activity and Antimicrobial Activity

Plasmodium falciparum is the cause of malaria, a life-threatening disease for thousands of years all around the World, particularly in Africa. The drug resistance is reducing the therapeutic efficiency for the treatment malarial and parasite. The in vitro antiplasmodial activity of (−)-anonaine was examined [5,32]. One study has reported that (−)-anonaine has antiplasmodial activity against both chloroquine sensitive D10 strain (IC50 values of 25.9 ± 0.2 μM) and chloroquine resistant D12 strain of Plasmodium falciparum (IC50 values of 19.6 ± 1.1 μM) with low cytotoxicity in a Chinese Hamster Ovarian cell line (CHO) [5]. Another study indicated that (−)-anonaine has antiplasmodial activity by in vitro radiometric Plasmodium falciparum growth inhibition assay (IC50 values of 7 ± 2 μM) [32].
The antimicrobial effects of (+)-anonaine have been described in several studies, however, the exact mechanism of action remains unclear [24,27,28]. Studies have shown that (+)-anonaine has strong inhibitory activities against Bacillus cereus, Escherichia coli, Micrococcus sp., Staphylococcus aureus and S. epidermidis and displays anti-fungus activities against Trichophyton rubrum and Microsporum gypseum growth [24,27,28].

7. Conclusions

With the current information, it is evident that anonaine has interesting pharmacological functions, including vasorelaxant, antbacterial, antifungal, antioxidative, anticancer and antidepressant effects. In addition, one approved U.S. patent reports that anonaine also has utility in the prevention and treatment of gastrointestinal dyskinetic diseases (US patent number US7198804) [33]. However, there is lack of correlation between in vitro and in vivo studies on the effects of anonaine Toxicity studies are missing too. For this reason, extensive pharmacological, chemical experiments and metabolism studies should be undertaken. Last but not least, this article aims to provide useful information about anonaine for researchers in this field.

Acknowledgments

This investigation was supported by a grant from the Fooyin University.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Wang, H.M.; Lo, W.L.; Huang, L.Y.; Wang, Y.D.; Chen, C.Y. Chemical constituents from the leaves of Michelia alba. Nat. Prod. Res. 2010, 24, 398–406. [Google Scholar] [PubMed]
  2. Martinez-Vazquez, M.; Estrada-Reyes, R.; Araujo Escalona, A.G.; Ledesma Velazquez, I.; Martinez-Mota, L.; Moreno, J.; Heinze, G. Antidepressant-like effects of an alkaloid extract of the aerial parts of Annona cherimolia in mice. J. Ethnopharmacol. 2012, 139, 164–170. [Google Scholar] [CrossRef] [PubMed]
  3. Costa, E.V.; da Cruz, P.E.; de Lourenco, C.C.; de Souza Moraes, V.R.; de Lima Nogueira, P.C.; Salvador, M.J. Antioxidant and antimicrobial activities of aporphinoids and other alkaloids from the bark of Annona salzmannii A. DC. (Annonaceae). Nat. Prod. Res. 2012, 27, 1002–1006. [Google Scholar] [CrossRef] [PubMed]
  4. Yeh, Y.T.; Huang, J.C.; Kuo, P.L.; Chen, C.Y. Bioactive constituents from Michelia champaca. Nat. Prod. Commun. 2011, 6, 1251–1252. [Google Scholar] [PubMed]
  5. Graziose, R.; Rathinasabapathy, T.; Lategan, C.; Poulev, A.; Smith, P.J.; Grace, M.; Lila, M.A.; Raskin, I. Antiplasmodial activity of aporphine alkaloids and sesquiterpene lactones from Liriodendron tulipifera L. J. Ethnopharmacol. 2011, 133, 26–30. [Google Scholar] [CrossRef] [PubMed]
  6. Chen, B.H.; Chang, H.W.; Huang, H.M.; Chong, I.W.; Chen, J.S.; Chen, C.Y.; Wang, H.M. (−)-Anonaine induces DNA damage and inhibits growth and migration of human lung carcinoma h1299 cells. J. Agric. Food Chem. 2011, 59, 2284–2290. [Google Scholar] [CrossRef] [PubMed]
  7. Mohamed, S.M.; Hassan, E.M.; Ibrahim, N.A. Cytotoxic and antiviral activities of aporphine alkaloids of Magnolia grandiflora L. Nat. Prod. Res. 2010, 24, 1395–1402. [Google Scholar] [CrossRef] [PubMed]
  8. Hu, R.; Dai, X.; Lu, Y.; Pan, Y. Preparative separation of isoquinoline alkaloids from Stephania yunnanensis by pH-zone-refining counter-current chromatography. J. Chromatogr. B 2010, 878, 1881–1884. [Google Scholar] [CrossRef] [PubMed]
  9. Garro, H.A.; Juri Ayub, M.; Nieto, M.; Lucero Estrada, C.; Pungitore, C.R.; Tonn, C.E. The trypanocidal activity of the alkaloid oliverine involves inhibition of DNA synthesis. Cell Mol. Biol. (Noisy-le-grand) 2010, 56, OL1318–OL1323. [Google Scholar]
  10. Costa, E.V.; Pinheiro, M.L.; Barison, A.; Campos, F.R.; Salvador, M.J.; Maia, B.H.; Cabral, E.C.; Eberlin, M.N. Alkaloids from the bark of Guatteria hispida and their evaluation as antioxidant and antimicrobial agents. J. Nat. Prod. 2010, 73, 1180–1183. [Google Scholar] [CrossRef] [PubMed]
  11. Alias, A.; Hazni, H.; Jaafar, F.M.; Awang, K.; Ismail, N.H. Alkaloids from Fissistigma latifolium (Dunal) Merr. Molecules 2010, 15, 4583–4588. [Google Scholar] [CrossRef] [PubMed]
  12. Sashidhara, K.V.; Singh, S.P.; Shukla, P.K. Antimicrobial evaluation of clerodane diterpenes from Polyalthia longifolia var. pendula. Nat. Prod. Commun. 2009, 4, 327–330. [Google Scholar] [PubMed]
  13. Lee, J.J.; Jin, C.M.; Kim, Y.K.; Ryu, S.Y.; Lim, S.C.; Lee, M.K. Effects of anonaine on dopamine biosynthesis and L-DOPA-induced cytotoxicity in PC12 cells. Molecules 2008, 13, 475–487. [Google Scholar] [CrossRef] [PubMed]
  14. Correche, E.R.; Andujar, S.A.; Kurdelas, R.R.; Gomez Lechon, M.J.; Freile, M.L.; Enriz, R.D. Antioxidant and cytotoxic activities of canadine: Biological effects and structural aspects. Bioorg. Med. Chem. 2008, 16, 3641–3651. [Google Scholar] [CrossRef] [PubMed]
  15. Chen, C.Y.; Liu, T.Z.; Tseng, W.C.; Lu, F.J.; Hung, R.P.; Chen, C.H.; Chen, C.H. (−)-Anonaine induces apoptosis through Bax- and caspase-dependent pathways in human cervical cancer (HeLa) cells. Food Chem. Toxicol. 2008, 46, 2694–2702. [Google Scholar] [CrossRef] [PubMed]
  16. Valiente, M.; D'Ocon, P.; Noguera, M.A.; Cassels, B.K.; Lugnier, C.; Ivorra, M.D. Vascular activity of (−)-anonaine, (−)-roemerine and (−)-pukateine, three natural 6a(R)-1,2-methylenedioxyaporphines with different affinities for alpha1-adrenoceptor subtypes. Planta Med. 2004, 70, 603–609. [Google Scholar] [CrossRef] [PubMed]
  17. Sette, I.M.; da-Cunha, E.V.; Barbosa-Filho, J.M.; da-Silva, M.S. Tetrahydroprotoberberine and aporphine alkaloids from rollinia leptopetala. Pharm. Biol. 2000, 38, 318–320. [Google Scholar] [CrossRef]
  18. Hasrat, J.A.; De Bruyne, T.; De Backer, J.P.; Vauquelin, G.; Vlietinck, A.J. Isoquinoline derivatives isolated from the fruit of Annona muricata as 5-HTergic 5-HT1A receptor agonists in rats: unexploited antidepressive (lead) products. J. Pharm. Pharmacol. 1997, 49, 1145–1149. [Google Scholar] [CrossRef] [PubMed]
  19. Protais, P.; Arbaoui, J.; Bakkali, E.H.; Bermejo, A.; Cortes, D. Effects of various isoquinoline alkaloids on in vitro 3H-dopamine uptake by rat striatal synaptosomes. J. Nat. Prod. 1995, 58, 1475–1484. [Google Scholar] [CrossRef] [PubMed]
  20. Chulia, S.; Ivorra, M.D.; Cave, A.; Cortes, D.; Noguera, M.A.; D'Ocon, M.P. Relaxant activity of three aporphine alkaloids from Annona cherimolia on isolated aorta of rat. J. Pharm. Pharmacol. 1995, 47, 647–650. [Google Scholar] [CrossRef] [PubMed]
  21. Ubeda, A.; Montesinos, C.; Paya, M.; Terencio, C.; Alcaraz, M.J. Antioxidant action of benzylisoquinoline alkaloids. Free Radic. Res. Commun. 1993, 18, 167–175. [Google Scholar] [CrossRef] [PubMed]
  22. Ubeda, A.; Montesinos, C.; Paya, M.; Alcaraz, M.J. Iron-reducing and free-radical-scavenging properties of apomorphine and some related benzylisoquinolines. Free Radic. Biol. Med. 1993, 15, 159–167. [Google Scholar] [CrossRef]
  23. Yang, X.J.; Xu, L.Z.; Sun, N.J.; Wang, S.C. Studies on the chemical constituents of Annona squamosa. Yao Xue Xue Bao 1992, 27, 185–190. [Google Scholar] [PubMed]
  24. Paulo Mde, Q.; Barbosa-Filho, J.M.; Lima, E.O.; Maia, R.F.; Barbosa Rde, C.; Kaplan, M.A. Antimicrobial activity of benzylisoquinoline alkaloids from Annona salzmanii D.C. J. Ethnopharmacol. 1992, 36, 39–41. [Google Scholar] [CrossRef]
  25. Martinez, L.A.; Rios, J.L.; Paya, M.; Alcaraz, M.J. Inhibition of nonenzymic lipid peroxidation by benzylisoquinoline alkaloids. Free Radic. Biol. Med. 1992, 12, 287–292. [Google Scholar] [CrossRef]
  26. Cortes, D.; Torrero, M.Y.; Pilar D'Ocon, M.; Luz Candenas, M.; Cave, A.; Hadi, A.H. Norstephalagine and atherospermidine: Two smooth muscle relaxant aporphines from Artabotrys maingayi. J. Nat. Prod. 1990, 53, 503–508. [Google Scholar] [CrossRef] [PubMed]
  27. Tsai, I.L.; Liou, Y.F.; Lu, S.T. Screening of isoquinoline alkaloids and their derivatives for antibacterial and antifungal activities. Gaoxiong Yi Xue Ke Xue Za Zhi 1989, 5, 132–145. [Google Scholar] [PubMed]
  28. Villar, A.; Mares, M.; Rios, J.L.; Canton, E.; Gobernado, M. Antimicrobial activity of benzylisoquinoline alkaloids. Pharmazie 1987, 42, 248–250. [Google Scholar] [PubMed]
  29. Ohiri, F.C.; Verpoorte, R.; Baerheim Svendsen, A. Alkaloids from Chasmanthera dependens. Planta Med. 1982, 46, 228–230. [Google Scholar] [CrossRef] [PubMed]
  30. Zelenski, S.G. Alkaloids of Nelumbo lutea (Wild.) pers. (Nymphaeaceae). J. Pharm. Sci. 1977, 66, 1627–1628. [Google Scholar] [CrossRef] [PubMed]
  31. Barton, D.H.; Bhakuni, D.S.; Chapman, G.M.; Kirby, G.W. Phenol oxidation and biosynthesis. XV. The biosynthesis of roemerine, anonaine, and mecambrine. J. Chem. Soc. Perkin Trans. 1 1967, 21, 2134–2140. [Google Scholar] [CrossRef] [PubMed]
  32. Levrier, C.; Balastrier, M.; Beattie, K.D.; Carroll, A.R.; Martin, F.; Choomuenwai, V.; Davis, R.A. Pyridocoumarin, aristolactam and aporphine alkaloids from the Australian rainforest plant Goniothalamus australis. Phytochemistry 2013, 86, 121–126. [Google Scholar] [CrossRef] [PubMed]
  33. Cho, B.W.; Jin, M.; Jun, H.J.; Kim, S. Crude drug composition for preventing and treating gastrointestinal dyskinetic diseases. U.S. Patent 7198804, 2007. [Google Scholar]
Figure 1. Chemical structure of (−)-anonaine (A) and anonaine derivative (B).
Figure 1. Chemical structure of (−)-anonaine (A) and anonaine derivative (B).
Molecules 18 08257 g001
Scheme 1. The possible mechanism of action of (−)-anonaine-induced apoptosis and cell cycle arrest in cancer cells.
Scheme 1. The possible mechanism of action of (−)-anonaine-induced apoptosis and cell cycle arrest in cancer cells.
Molecules 18 08257 sch001
Table 1. Anonaine isolated from plants and its pharmacological effects.
Table 1. Anonaine isolated from plants and its pharmacological effects.
SourcePharmacological effects
  • Goniothalamus australis
  • aerial parts of Annona cherimola
  • bark of Annona salzmannii
  • Michelia champaca
  • Liriodendron tulipifera
  • leaves of Michlia alba
  • Magnolia grandiflora
  • Stephania yunnanensis
  • bark of Guatteria hispida
  • Fissistigma latifolium
  • Polyalthia longifolia
  • Rollinia leptopetala
  • fruit of Annona muricata
  • Annona cherimolia
  • Annona squamosa
  • Artabotrys maingayi
  • Chamanthera dependens
  • Nelumbo lutea
  • antoxidant activity
  • antidepression
  • anticancer activity
  • vasorelaxant activity
  • antiplasmodial activity
  • antibacterial activity
  • antifungal activity

Share and Cite

MDPI and ACS Style

Li, H.-T.; Wu, H.-M.; Chen, H.-L.; Liu, C.-M.; Chen, C.-Y. The Pharmacological Activities of (−)-Anonaine. Molecules 2013, 18, 8257-8263. https://doi.org/10.3390/molecules18078257

AMA Style

Li H-T, Wu H-M, Chen H-L, Liu C-M, Chen C-Y. The Pharmacological Activities of (−)-Anonaine. Molecules. 2013; 18(7):8257-8263. https://doi.org/10.3390/molecules18078257

Chicago/Turabian Style

Li, Hsing-Tan, Hui-Ming Wu, Hsin-Liang Chen, Chi-Ming Liu, and Chung-Yi Chen. 2013. "The Pharmacological Activities of (−)-Anonaine" Molecules 18, no. 7: 8257-8263. https://doi.org/10.3390/molecules18078257

Article Metrics

Back to TopTop